AbbVie Historical Financial Ratios

ABBV Stock

USD 176.95 5.22 3.04%

AbbVie is presently reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0289, PTB Ratio of 17.2 or Days Sales Outstanding of 79.75 will help investors to properly organize and evaluate AbbVie Inc financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About AbbVie Financial Ratios Analysis

AbbVie IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate AbbVie investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on AbbVie financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across AbbVie history.

AbbVie Financial Ratios Chart

At this time, AbbVie's Payout Ratio is fairly stable compared to the past year. PFCF Ratio is likely to climb to 15.04 in 2024, whereas Dividend Yield is likely to drop 0.03 in 2024.

Price To Sales Ratio Dividend Yield Days Sales Outstanding Book Value Per Share Free Cash Flow Yield Capex To Revenue

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing AbbVie Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on AbbVie sales, a figure that is much harder to manipulate than other AbbVie Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is AbbVie Inc dividend as a percentage of AbbVie stock price. AbbVie Inc dividend yield is a measure of AbbVie stock productivity, which can be interpreted as interest rate earned on an AbbVie investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most ratios from AbbVie's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into AbbVie Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

At this time, AbbVie's Payout Ratio is fairly stable compared to the past year. PFCF Ratio is likely to climb to 15.04 in 2024, whereas Dividend Yield is likely to drop 0.03 in 2024.

	2021	2022	2023	2024 (projected)
Dividend Yield	0.0386	0.0351	0.0385	0.0289
Price To Sales Ratio	4.26	4.93	5.04	3.39

Dividend Yield Price To Sales Ratio

AbbVie fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		-0.12	0.47	-0.36	0.02	-0.62	0.12	0.22	0.47	0.85	0.11	-0.58	-0.06	0.06	0.01	-0.45	0.04	0.06	0.55	-0.57	0.14	0.3	0.52	0.29	0.06	0.04
Dividend Yield	-0.12		-0.61	-0.52	-0.24	0.49	0.47	-0.43	-0.61	0.21	0.47	-0.35	0.1	0.52	-0.09	-0.08	-0.59	0.63	-0.49	-0.37	0.05	-0.48	-0.49	-0.1	0.15	-0.63
Ptb Ratio	0.47	-0.61		0.2	0.29	-0.75	-0.22	0.38	1.0	0.35	-0.22	-0.3	-0.32	-0.4	0.26	-0.4	0.43	-0.35	0.78	-0.18	0.27	0.64	0.77	0.43	0.08	0.75
Days Sales Outstanding	-0.36	-0.52	0.2		0.35	0.08	-0.31	0.13	0.2	-0.56	-0.3	0.53	-0.24	-0.42	0.24	0.23	0.34	-0.42	-0.13	0.54	-0.04	0.05	-0.11	-0.01	-0.01	0.49
Book Value Per Share	0.02	-0.24	0.29	0.35		0.13	0.19	-0.34	0.29	-0.05	0.19	-0.01	0.25	0.1	-0.11	0.42	-0.27	-0.6	-0.16	0.29	0.03	-0.2	-0.16	-0.24	0.11	0.4
Free Cash Flow Yield	-0.62	0.49	-0.75	0.08	0.13		0.21	-0.55	-0.75	-0.46	0.21	0.43	0.38	0.39	-0.3	0.61	-0.62	0.11	-0.92	0.49	-0.29	-0.7	-0.9	-0.59	-0.09	-0.35
Operating Cash Flow Per Share	0.12	0.47	-0.22	-0.31	0.19	0.21		-0.84	-0.22	0.37	1.0	-0.37	-0.17	0.59	0.32	-0.33	-0.7	0.22	-0.31	-0.54	0.56	-0.67	-0.34	0.3	0.7	-0.3
Capex To Depreciation	0.22	-0.43	0.38	0.13	-0.34	-0.55	-0.84		0.38	-0.03	-0.85	0.06	-0.04	-0.53	-0.12	-0.08	0.84	-0.1	0.61	0.11	-0.37	0.85	0.63	0.05	-0.57	0.25
Pb Ratio	0.47	-0.61	1.0	0.2	0.29	-0.75	-0.22	0.38		0.35	-0.22	-0.3	-0.32	-0.4	0.26	-0.4	0.43	-0.35	0.78	-0.18	0.27	0.64	0.77	0.43	0.08	0.75
Ev To Sales	0.85	0.21	0.35	-0.56	-0.05	-0.46	0.37	-0.03	0.35		0.36	-0.83	-0.1	0.26	0.05	-0.61	-0.23	0.17	0.35	-0.82	0.22	0.06	0.31	0.33	0.21	0.04
Free Cash Flow Per Share	0.11	0.47	-0.22	-0.3	0.19	0.21	1.0	-0.85	-0.22	0.36		-0.36	-0.17	0.59	0.32	-0.32	-0.71	0.22	-0.32	-0.53	0.55	-0.68	-0.35	0.29	0.69	-0.3
Roic	-0.58	-0.35	-0.3	0.53	-0.01	0.43	-0.37	0.06	-0.3	-0.83	-0.36		0.2	-0.01	-0.18	0.57	0.09	-0.11	-0.33	0.82	-0.47	-0.09	-0.3	-0.41	-0.45	0.07
Inventory Turnover	-0.06	0.1	-0.32	-0.24	0.25	0.38	-0.17	-0.04	-0.32	-0.1	-0.17	0.2		0.35	-0.97	0.73	-0.2	-0.15	-0.22	0.35	-0.61	-0.03	-0.21	-0.91	-0.55	-0.22
Net Income Per Share	0.06	0.52	-0.4	-0.42	0.1	0.39	0.59	-0.53	-0.4	0.26	0.59	-0.01	0.35		-0.29	0.01	-0.76	0.36	-0.45	-0.26	-0.29	-0.59	-0.46	-0.25	-0.16	-0.21
Days Of Inventory On Hand	0.01	-0.09	0.26	0.24	-0.11	-0.3	0.32	-0.12	0.26	0.05	0.32	-0.18	-0.97	-0.29		-0.66	0.1	0.07	0.13	-0.32	0.7	-0.11	0.11	0.91	0.68	0.16
Payables Turnover	-0.45	-0.08	-0.4	0.23	0.42	0.61	-0.33	-0.08	-0.4	-0.61	-0.32	0.57	0.73	0.01	-0.66		-0.11	-0.31	-0.46	0.84	-0.51	-0.15	-0.43	-0.87	-0.44	-0.16
Capex To Revenue	0.04	-0.59	0.43	0.34	-0.27	-0.62	-0.7	0.84	0.43	-0.23	-0.71	0.09	-0.2	-0.76	0.1	-0.11		-0.21	0.67	0.12	0.0	0.83	0.69	0.21	-0.2	0.22
Cash Per Share	0.06	0.63	-0.35	-0.42	-0.6	0.11	0.22	-0.1	-0.35	0.17	0.22	-0.11	-0.15	0.36	0.07	-0.31	-0.21		-0.08	-0.37	0.02	-0.14	-0.08	0.11	0.0	-0.53
Pocfratio	0.55	-0.49	0.78	-0.13	-0.16	-0.92	-0.31	0.61	0.78	0.35	-0.32	-0.33	-0.22	-0.45	0.13	-0.46	0.67	-0.08		-0.34	0.26	0.87	1.0	0.43	0.0	0.31
Interest Coverage	-0.57	-0.37	-0.18	0.54	0.29	0.49	-0.54	0.11	-0.18	-0.82	-0.53	0.82	0.35	-0.26	-0.32	0.84	0.12	-0.37	-0.34		-0.44	0.01	-0.3	-0.59	-0.43	0.14
Payout Ratio	0.14	0.05	0.27	-0.04	0.03	-0.29	0.56	-0.37	0.27	0.22	0.55	-0.47	-0.61	-0.29	0.7	-0.51	0.0	0.02	0.26	-0.44		-0.04	0.26	0.7	0.95	-0.11
Capex To Operating Cash Flow	0.3	-0.48	0.64	0.05	-0.2	-0.7	-0.67	0.85	0.64	0.06	-0.68	-0.09	-0.03	-0.59	-0.11	-0.15	0.83	-0.14	0.87	0.01	-0.04		0.89	0.13	-0.31	0.3
Pfcf Ratio	0.52	-0.49	0.77	-0.11	-0.16	-0.9	-0.34	0.63	0.77	0.31	-0.35	-0.3	-0.21	-0.46	0.11	-0.43	0.69	-0.08	1.0	-0.3	0.26	0.89		0.41	-0.01	0.3
Days Payables Outstanding	0.29	-0.1	0.43	-0.01	-0.24	-0.59	0.3	0.05	0.43	0.33	0.29	-0.41	-0.91	-0.25	0.91	-0.87	0.21	0.11	0.43	-0.59	0.7	0.13	0.41		0.61	0.17
Income Quality	0.06	0.15	0.08	-0.01	0.11	-0.09	0.7	-0.57	0.08	0.21	0.69	-0.45	-0.55	-0.16	0.68	-0.44	-0.2	0.0	0.0	-0.43	0.95	-0.31	-0.01	0.61		-0.18
Roe	0.04	-0.63	0.75	0.49	0.4	-0.35	-0.3	0.25	0.75	0.04	-0.3	0.07	-0.22	-0.21	0.16	-0.16	0.22	-0.53	0.31	0.14	-0.11	0.3	0.3	0.17	-0.18

Click cells to compare fundamentals

AbbVie Account Relationship Matchups

AbbVie fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	3.94	3.9	4.26	4.93	5.04	3.39
Dividend Yield	0.0485	0.0432	0.0386	0.0351	0.0385	0.0289
Ptb Ratio	(16.05)	13.66	15.55	16.59	26.45	17.2
Days Sales Outstanding	59.56	70.3	64.8	70.76	74.96	79.75
Book Value Per Share	(5.52)	7.86	8.72	9.76	5.88	3.02
Free Cash Flow Yield	0.0974	0.094	0.0918	0.0847	0.0805	0.065
Operating Cash Flow Per Share	9.0	10.55	12.87	14.08	12.92	13.56
Capex To Depreciation	0.27	0.12	0.0924	0.0821	0.0893	0.0849
Pb Ratio	(16.05)	13.66	15.55	16.59	26.45	17.2
Ev To Sales	4.75	5.59	5.46	5.86	5.9	4.02
Free Cash Flow Per Share	8.62	10.07	12.42	13.69	12.48	13.1
Inventory Turnover	4.1	4.65	5.58	4.87	2.14	2.03
Net Income Per Share	5.32	2.77	6.52	6.68	2.75	2.8
Days Of Inventory On Hand	88.96	78.52	65.44	75.02	170.4	178.92
Payables Turnover	5.12	6.76	6.05	5.94	2.38	2.26
Capex To Revenue	0.0195	0.0166	0.0174	0.014	0.012	0.0143
Cash Per Share	26.96	5.09	5.55	5.21	7.25	5.0
Pocfratio	9.84	10.16	10.52	11.47	12.0	13.89
Interest Coverage	7.28	4.63	7.4	8.12	5.74	5.45
Payout Ratio	0.81	1.67	0.8	0.85	2.17	2.28
Capex To Operating Cash Flow	0.0414	0.0454	0.0346	0.0279	0.034	0.0323
Pfcf Ratio	10.27	10.64	10.9	11.8	12.42	15.04
Days Payables Outstanding	71.24	53.99	60.3	61.5	153.32	160.98
Income Quality	1.69	3.81	1.97	2.11	4.68	4.91
Roe	(0.96)	0.35	0.75	0.69	0.47	0.65
Ev To Operating Cash Flow	11.85	14.57	13.46	13.64	14.04	11.98
Pe Ratio	16.64	38.7	20.76	24.18	56.34	59.16
Ev To Free Cash Flow	12.37	15.26	13.94	14.03	14.53	17.79
Earnings Yield	0.0601	0.0258	0.0482	0.0414	0.0177	0.0169
Intangibles To Total Assets	0.38	0.77	0.74	0.72	0.65	0.43
Net Debt To E B I T D A	2.41	1.65	3.67	2.37	1.72	1.77
Current Ratio	3.18	0.84	0.79	0.96	0.87	1.71
Tangible Book Value Per Share	(28.65)	(61.73)	(52.48)	(46.48)	(43.84)	(46.03)
Receivables Turnover	6.13	5.19	5.63	5.16	4.87	4.09
Graham Number	25.71	22.11	35.74	38.28	19.04	15.97

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

AbbVie Historical Financial Ratios

About AbbVie Financial Ratios Analysis

AbbVie Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Book Value Per Share

Free Cash Flow Yield

Capex To Revenue

AbbVie fundamentals Correlations

AbbVie Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AbbVie fundamentals Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for AbbVie Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Income Quality	+ 0.95	Payout Ratio
Days Payables Outstanding	+ 0.91	Days Of Inventory On Hand
Pfcf Ratio	+ 0.89	Capex To Operating Cash Flow

Days Of Inventory On Hand	- 0.97	Inventory Turnover
Pocfratio	- 0.92	Free Cash Flow Yield
Days Payables Outstanding	- 0.91	Inventory Turnover
Pfcf Ratio	- 0.9	Free Cash Flow Yield
Days Payables Outstanding	- 0.87	Payables Turnover
Free Cash Flow Per Share	- 0.85	Capex To Depreciation